Long Term Inhibition by Estradiol or Progesterone of Melatonin Secretion After Administration of a Mammary Carcinogen, the Dimethyl Benz(a)anthracene, in Sprague-Dawley Female Rat; Inhibitory Effect of Melatonin on Mammary Carcinogenesis
暂无分享,去创建一个
[1] J. Russo,et al. Differentiation of the mammary gland and susceptibility to carcinogenesis , 2005, Breast Cancer Research and Treatment.
[2] S. Hill,et al. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesis , 2005, Journal of Neural Transmission.
[3] M. Jimenez-Linan,et al. Long-term Effects of the Mammary Carcinogen 7,12-Dimethylbenz(a) Anthracene on Hypothalamic Gonadotropin-Releasing Hormone and its Pituitary Receptor Gene Expression, During the Promotion Stage, in Female Sprague-Dawley Rats , 2002, Breast Cancer Research and Treatment.
[4] S. Cos,et al. Melatonin and Mammary Pathological Growth , 2000, Frontiers in Neuroendocrinology.
[5] Y. Touitou,et al. Progesterone inhibits, on a circadian basis, the release of melatonin by rat pineal perifusion , 2000, Steroids.
[6] A. Amemiya,et al. Melatonin secretion from organ-cultured pineal glands of rats: modulation by gonadectomy and gonadotropin-releasing hormone agonist administration. , 2000, European journal of endocrinology.
[7] D. Blask,et al. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. , 1999, Cancer research.
[8] S. Cos,et al. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. , 1999, Life sciences.
[9] J. Vanecek. Inhibitory effect of melatonin on GnRH-induced LH release. , 1999, Reviews of reproduction.
[10] P. S. Lazo,et al. Melatonin blocks the activation of estrogen receptor for DNA binding , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] S. Cos,et al. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. , 1998, Cancer research.
[12] J. Alexander,et al. A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression. , 1998, Molecular endocrinology.
[13] R C Garner,et al. The role of DNA adducts in chemical carcinogenesis. , 1998, Mutation research.
[14] B. Kerdelhué,et al. The in vitro effect of substance P on the GnRH-induced LH release depends on the steroidal environment and is reverted by a NK1 receptor antagonist (RP 67580) in the cycling female rat , 1998, Neuropeptides.
[15] E. Cavalieri,et al. Determination of benzo[a]pyrene- and 7,12-dimethylbenz[a]anthracene-DNA adducts formed in rat mammary glands. , 1997, Chemical research in toxicology.
[16] R. Alonso,et al. Ovarian hormones regulate alpha 1- and beta-adrenoceptor interactions in female rat pinealocytes. , 1995, Neuroreport.
[17] S. Hill,et al. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. , 1994, Molecular endocrinology.
[18] D. Cardinali,et al. 2-[125I]iodomelatonin binding sites in murine mammary tissue. , 1994, Biological signals.
[19] R. Alonso,et al. Progesterone does not mediate the inhibition of pineal melatonin production during the rat proestrous night , 1993, Neuroscience Letters.
[20] L. Garcia-Segura,et al. Estrogen-like effects of the mammary carcinogen 7,12-dimethylbenz(a)anthracene on hypothalamic neuronal membranes , 1992, Brain Research Bulletin.
[21] W. McGuire,et al. Estrogen receptor variants in clinical breast cancer. , 1991, Molecular endocrinology.
[22] A Subramanian,et al. Suppressive effect by melatonin on different phases of 9,10‐dimethyl-1,2‐benzanthracene (DMBA)-induced rat mammary gland carcinogenesis , 1991, Anti-cancer drugs.
[23] H. Bartsch,et al. Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism , 1991, Cancer.
[24] R. Alonso,et al. Ovarian steroids block the isoproterenol-induced elevation of pineal melatonin production in the female rat , 1990, Neuroscience Letters.
[25] C. Pasqualini,et al. Estrogen-like effects of 7,12-dimethylbenz(a)anthracene on the female rat hypothalamo-pituitary axis. , 1990, Journal of steroid biochemistry.
[26] H. Bartsch,et al. Effect of the mammary carcinogen 7,12-dimethylbenz[a]anthracene on pineal melatonin biosynthesis, secretion and peripheral metabolism. , 1990, Neuroendocrinology.
[27] H. Vaudry,et al. Kinetic Study of Melatonin Release From Rat Pineal Glands Using a Perifusion Technique , 1989, Journal of pineal research.
[28] J. Arendt,et al. Entrainment of melatonin rhythms in rams by symmetrical light-dark cycles of different period length. , 1989, Chronobiology international.
[29] S. Hill,et al. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. , 1988, Cancer research.
[30] B. Kerdelhué,et al. Stimulation of estradiol-17 beta secretion by 7,12-dimethylbenz (a) anthracene during mammary tumor induction in Sprague-Dawley rats. , 1987, Journal of steroid biochemistry.
[31] Chawnshang Chang,et al. Topographic recognition of cyclic hydrocarbons and related compounds by receptors for androgens, estrogens, and glucocorticoids. , 1987, Journal of steroid biochemistry.
[32] D. Cardinali,et al. Neuroendocrine integrative mechanisms in mammalian pineal gland: effects of steroid and adenohypophysial hormones on melatonin synthesis in vitro. , 1987, Journal of steroid biochemistry.
[33] J. Russo,et al. Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. , 1983, The American journal of pathology.
[34] M. Lippman,et al. Melatonin increases oestrogen receptor binding activity of human breast cancer cells , 1983, Nature.
[35] F. Daniel,et al. DNA adduct formation by 7,12-dimethylbenz[a]anthracene and its noncarcinogenic 2-fluoro analogue in female Sprague-Dawley rats. , 1983, Journal of the National Cancer Institute.
[36] M. Lippman,et al. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. , 1982, Science.
[37] M. Cohen,et al. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. , 1981, Cancer research.
[38] B. Kerdelhué,et al. In vitro LHRH release: Correlation with the LH surge and alteration by a mammary carcinogen , 1981, Peptides.
[39] R. Reiter. The pineal and its hormones in the control of reproduction in mammals. , 1980, Endocrine reviews.
[40] B. Kerdelhué,et al. Inhibition of preovulatory gonadotropin secretion and stimulation of prolactin secretion by 7,12-dimethylbenz(a)anthracene in Sprague-Dawley rats. , 1979, Cancer research.
[41] D. Cardinali. Nuclear receptor estrogen complex in the pineal gland. Modulation by sympathetic nerves. , 1977, Neuroendocrinology.
[42] T. Dao. The role of ovarian hormones in initiating the induction of mammary cancer in rats by polynuclear hydrocarbons. , 1962, Cancer research.
[43] C. Huggins,et al. Mammary Cancer Induced by a Single Feeding of Polynuclear Hydrocarbons, and its Suppression , 1961, Nature.
[44] N. Goodman. New Research Laboratories of Hilger and Watts, Ltd. , 1961, Nature.